Antares Pharma reports plans to price public offering of common stock

Bookrunner Piper Jaffray raises funds for general corporate purposes

By Devika Patel

Knoxville, Tenn., May 5 – Antares Pharma, Inc. will price a public offering of common stock with a 30-day greenshoe, according to a preliminary prospectus supplement filed Tuesday with the Securities and Exchange Commission.

Piper Jaffray is the bookrunner.

Proceeds will be used for general corporate purposes, including business development, in-licensing and acquisitions.

Located in Ewing, N.J., Antares is a pharmaceutical company focused on self-injection pharmaceutical products and technologies and topical gel-based products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.